"See Attractive Risk-Reward" - Oppenheimer Soleno Therapeutics (SLNO) at Outperform with $3 Price Target
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell reiterated an Outperform rating and $3.00 price target on Soleno Therapeutics Inc. (NASDAQ: SLNO), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
